Cite
HARVARD Citation
Mascarenhas, J. et al. (n.d.). A phase I study of panobinostat (LBH589) in patients with primary myelofibrosis (PMF) and post‐polycythaemia vera/essential thrombocythaemia myelofibrosis (post‐PV/ET MF). British journal of haematology. pp. 68-75. [Online].